Download Vetter Pharma's whitepaper on Maximizing injectables production: Enabling consistent supply

One of the most significant trends today in our industry is the enormous growth of the injectable market. Injectables are becoming the single largest driver of the pharma/biotech market and offer tremendous opportunity.

However, bringing an injectable to market is no small feat. Staying competitive, once in the market, can be just as challenging. Market and regulatory requirements regarding safety and quality are constantly increasing. Thus, an experienced partner who understands today´s challenges of clinical and commercial production is vital and can facilitate global market supply.

We will be gathering inspiring biotech leaders in Asia's biopharma industry together at the 10th BioPharma Asia Convention 2017 , happening in Singapore on 21-23 March . Leading biotech entrepreneurs, biopharma organizations and associations, and big pharma players from both APAC and international will offer you a 360 degree overview of how India is innovating to lead the race to Asia’s biopharma future.

Find out more: http://www.terrapinn.com/exhibition/bio-asia/index.stm

To sign up, contact Sunny Wilson at sunny.wilson@terrapinn.com or +65 6322 2340.